Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation. AuroLase, the company's lead product for the ablation of prostate cancer tissue, is the first and only ultra-focal tissue ablation therapy designed to maximize treatment efficacy while minimizing side effects typically associated with surgery, radiation, and traditional focal therapies. Implementing a multi-prong growth strategy, Nanospectra is focusing on clinical advancements, exclusive partnering agreements and ongoing research and development. Nanospectra’s technology development has been funded to date by a series of grants, private equity investments and corporate partnerships.
View Top Employees from Nanospectra Biosciences, Inc.Website | http://www.nanospectra.com |
Revenue | $1 million |
Funding | $10.6 million |
Employees | 10 (10 on RocketReach) |
Founded | 2002 |
Address | 8285 El Rio St, Houston, Texas 77030, US |
Phone | (713) 842-2720 |
Fax | (713) 440-9349 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Retail, Medical Equipment Manufacturing, Biotechnology, Science and Engineering, Health Care, Life Science, Pharmaceutical |
Web Rank | 15 Million |
Keywords | Nanospectra, Nanospectra Biosciences |
Competitors | Aura Biosciences, Formac Pharmaceuticals, Nanōmix, Phosphorex, XstalBio Limited |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Nanospectra Biosciences, Inc. employee's phone or email?
The Nanospectra Biosciences, Inc. annual revenue was $1 million in 2024.
Glenn Goodrich is the Vice President of Nanospectra Biosciences, Inc..
10 people are employed at Nanospectra Biosciences, Inc..
Nanospectra Biosciences, Inc. is based in Houston, Texas.
The NAICS codes for Nanospectra Biosciences, Inc. are [541, 541714, 5417, 54171, 54].
The SIC codes for Nanospectra Biosciences, Inc. are [873, 87].